Skip to content

Welcome CROss Alliance as a corporate member

Date: January 6, 2026

The Association for Clinical Data Management (ACDM) is delighted to welcome CROss Alliance as a new corporate member.

CROss Alliance® is a family-owned clinical CRO based in Canton Ticino, Switzerland, operating since 1996, with a high-standard FDA and Swissmedic inspected Phase I unit. The company supports hospital-based and Phase II studies through collaborations in Switzerland, Austria, and Central and Eastern Europe, delivering tailored, high-quality services across multiple therapeutic areas.

CROss Alliance joined ACDM to be part of a dynamic community and to keep up to date with training and professional development opportunities.

Members gain many benefits from membership, including:

  • Access to training courses at a discounted rate
  • Assign full ACDM membership to all individuals within your organisation
  • Place an organisation profile, description and logo on the ACDM website
  • Advertise jobs for your positions within your organisation
  • Reduced price attendance at conferences and symposia
  • Free attendance at Hot Topics

Find out more about becoming a corporate member here.

 


 

Explore More News

Clinical Trials for Medicines – New Notification Scheme

The MHRA have recently launched a new notification scheme, the first step in their . . .

Read More

EMA Management Board: Highlights of October 2023 meeting

The EMA’s Management Board met on 5 October in Amsterdam. The article below covers the . . .

Read More

Welcome Mednet as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Mednet as a new . . .

Read More

Welcome Allucent as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Allucent as a . . .

Read More

Welcome KCR as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome KCR as a new . . .

Read More

Welcome Debiopharm as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Debiopharm as a . . .

Read More

HMA/EMA joint Big Data Steering Group: Big Data Workplan 2023-2025

The joint HMA-EMA Big Data Steering Group (BDSG) have released their latest workplan, . . .

Read More

ACT EU PA04 – Multi-stakeholder Workshop on ICH E6 R3

As part of the Accelerating Clinical Trials in the EU (ACT EU) multi-annual workplan . . .

Read More

European Medicine’s Agency – Reflection paper on the use of artificial intelligence in the lifecycle of medicines

The EMA has opened a public consultation on a reflection paper presenting views . . .

Read More

Welcome Instem as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Instem as a new . . .

Read More

Regulatory Considerations Expert Group reviews draft FDA Guidance

The ACDM Regulatory Considerations Expert Group have reviewed and submitted comments on . . .

Read More

ICH GCP E6 Revision 3 is here. Regulatory Considerations Expert Group to review

The R&D industry, especially those that are working on clinical trials, have been . . .

Read More